NIH Funding Opportunities/Notices

NHLBI Funding Opportunities

RFA-AI-14-004 Beyond HAART: Innovative Approaches to Cure HIV-1 (U19)

This Funding Opportunity Announcement (FOA) invites applications from institutions/organizations to participate in the "Beyond HAART: Innovative Approaches to Cure HIV-1" initiative. The purpose of this FOA is to encourage investigators to work together on innovative approaches to eliminate HIV-1 and leverage the expertise and resources of the participating Institutes. Research topics of interest are as follows: cell therapies, including those based on hematopoietic stem cells; novel gene therapy approaches; and the development and delivery of non-traditional antiviral strategies (e.g. miRNAs, siRNAs, gene-editing enzymes). Applications are expected to include basic science/preclinical research as well as translational activities such as test-of-concept studies in animal models or humans. Applications must be designed as collaborative efforts between academia and the private sector.




PAR-13-114: Improvement of Animal Models for Stem Cell-Based Regenerative Medicine (R01)

This FOA encourages Research Project Grant (R01) applications from institutions and organizations proposing research aimed at characterizing animal stem cells and improving existing, and creating new, animal models for human disease conditions. The intent of this initiative is to facilitate the use of stem cell-based therapies for regenerative medicine. The initiative focuses on the following areas: 1) comparative analysis of animal and human stem cells to provide information for selection of the most predictive and informative model systems; 2) development of new technologies for stem cell characterization and transplantation; and 3) improvement of animal disease models for stem cell-based therapeutic applications.





PAR-13-115: Improvement of Animal Models for Stem Cell-Based Regenerative Medicine (R21)

This FOA encourages Exploratory/Developmental Research grant (R21) applications from institutions and organizations proposing research aimed at characterizing animal stem cells and improving existing, and creating new, animal models for human disease conditions. The intent of this initiative is to facilitate the use of stem cell-based therapies for regenerative medicine. The initiative focuses on the following areas: 1) comparative analysis of animal and human stem cells to provide information for selection of the most predictive and informative model systems; 2) development of new technologies for stem cell characterization and transplantation; and 3) improvement of animal disease models for stem cell-based therapeutic applications.